Medical Care

Global Gene Therapy Market Research Report 2025

The global market for Gene Therapy was valued at US$ 11480 million in the year 2024 and is projected to reach a revised size of US$ 61870 million by 2031, growing at a CAGR of 27.6% during the forecast period.
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.
Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy.
The Gene Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Roche
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
CSL Behring
BioMarin Pharmaceutical
Segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Market Perspective (2020-2031)
2.2 Global Gene Therapy Growth Trends by Region
2.2.1 Global Gene Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapy Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapy Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapy Market Dynamics
2.3.1 Gene Therapy Industry Trends
2.3.2 Gene Therapy Market Drivers
2.3.3 Gene Therapy Market Challenges
2.3.4 Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Players by Revenue
3.1.1 Global Top Gene Therapy Players by Revenue (2020-2025)
3.1.2 Global Gene Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Top Gene Therapy Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2024
3.5 Global Key Players of Gene Therapy Head office and Area Served
3.6 Global Key Players of Gene Therapy, Product and Application
3.7 Global Key Players of Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapy Forecasted Market Size by Type (2026-2031)
5 Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapy Market Size (2020-2031)
6.2 North America Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapy Market Size by Country (2020-2025)
6.4 North America Gene Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Market Size (2020-2031)
7.2 Europe Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapy Market Size by Country (2020-2025)
7.4 Europe Gene Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Market Size (2020-2031)
9.2 Latin America Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapy Market Size by Country (2020-2025)
9.4 Latin America Gene Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy Introduction
11.1.4 Biogen Revenue in Gene Therapy Business (2020-2025)
11.1.5 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy Introduction
11.2.4 Novartis Revenue in Gene Therapy Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy Introduction
11.3.4 Gilead Sciences Revenue in Gene Therapy Business (2020-2025)
11.3.5 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy Introduction
11.4.4 Sarepta Therapeutics Revenue in Gene Therapy Business (2020-2025)
11.4.5 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
11.5.4 Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2020-2025)
11.5.5 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy Introduction
11.6.4 Amgen Revenue in Gene Therapy Business (2020-2025)
11.6.5 Amgen Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Gene Therapy Introduction
11.7.4 Roche Revenue in Gene Therapy Business (2020-2025)
11.7.5 Roche Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy Introduction
11.8.4 Akcea Therapeutics Revenue in Gene Therapy Business (2020-2025)
11.8.5 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy Introduction
11.9.4 bluebird bio Revenue in Gene Therapy Business (2020-2025)
11.9.5 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy Introduction
11.10.4 Sunway Biotech Revenue in Gene Therapy Business (2020-2025)
11.10.5 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy Introduction
11.11.4 SIBIONO Revenue in Gene Therapy Business (2020-2025)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy Introduction
11.12.4 AnGes Revenue in Gene Therapy Business (2020-2025)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy Introduction
11.13.4 Orchard Therapeutics Revenue in Gene Therapy Business (2020-2025)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy Introduction
11.14.4 Human Stem Cells Institute Revenue in Gene Therapy Business (2020-2025)
11.14.5 Human Stem Cells Institute Recent Development
11.15 CSL Behring
11.15.1 CSL Behring Company Details
11.15.2 CSL Behring Business Overview
11.15.3 CSL Behring Gene Therapy Introduction
11.15.4 CSL Behring Revenue in Gene Therapy Business (2020-2025)
11.15.5 CSL Behring Recent Development
11.16 BioMarin Pharmaceutical
11.16.1 BioMarin Pharmaceutical Company Details
11.16.2 BioMarin Pharmaceutical Business Overview
11.16.3 BioMarin Pharmaceutical Gene Therapy Introduction
11.16.4 BioMarin Pharmaceutical Revenue in Gene Therapy Business (2020-2025)
11.16.5 BioMarin Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Gene Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-Viral Gene Therapy
Table 4. Global Gene Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy Market Share by Region (2020-2025)
Table 8. Global Gene Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Therapy Market Share by Region (2026-2031)
Table 10. Gene Therapy Market Trends
Table 11. Gene Therapy Market Drivers
Table 12. Gene Therapy Market Challenges
Table 13. Gene Therapy Market Restraints
Table 14. Global Gene Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Therapy Market Share by Players (2020-2025)
Table 16. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2024)
Table 17. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy, Product and Application
Table 21. Global Key Players of Gene Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy Product
Table 49. Biogen Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy Product
Table 54. Novartis Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Gilead Sciences Company Details
Table 57. Gilead Sciences Business Overview
Table 58. Gilead Sciences Gene Therapy Product
Table 59. Gilead Sciences Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 60. Gilead Sciences Recent Development
Table 61. Sarepta Therapeutics Company Details
Table 62. Sarepta Therapeutics Business Overview
Table 63. Sarepta Therapeutics Gene Therapy Product
Table 64. Sarepta Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 65. Sarepta Therapeutics Recent Development
Table 66. Alnylam Pharmaceuticals Company Details
Table 67. Alnylam Pharmaceuticals Business Overview
Table 68. Alnylam Pharmaceuticals Gene Therapy Product
Table 69. Alnylam Pharmaceuticals Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 70. Alnylam Pharmaceuticals Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Gene Therapy Product
Table 74. Amgen Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Gene Therapy Product
Table 79. Roche Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Akcea Therapeutics Company Details
Table 82. Akcea Therapeutics Business Overview
Table 83. Akcea Therapeutics Gene Therapy Product
Table 84. Akcea Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 85. Akcea Therapeutics Recent Development
Table 86. bluebird bio Company Details
Table 87. bluebird bio Business Overview
Table 88. bluebird bio Gene Therapy Product
Table 89. bluebird bio Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 90. bluebird bio Recent Development
Table 91. Sunway Biotech Company Details
Table 92. Sunway Biotech Business Overview
Table 93. Sunway Biotech Gene Therapy Product
Table 94. Sunway Biotech Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 95. Sunway Biotech Recent Development
Table 96. SIBIONO Company Details
Table 97. SIBIONO Business Overview
Table 98. SIBIONO Gene Therapy Product
Table 99. SIBIONO Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 100. SIBIONO Recent Development
Table 101. AnGes Company Details
Table 102. AnGes Business Overview
Table 103. AnGes Gene Therapy Product
Table 104. AnGes Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 105. AnGes Recent Development
Table 106. Orchard Therapeutics Company Details
Table 107. Orchard Therapeutics Business Overview
Table 108. Orchard Therapeutics Gene Therapy Product
Table 109. Orchard Therapeutics Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 110. Orchard Therapeutics Recent Development
Table 111. Human Stem Cells Institute Company Details
Table 112. Human Stem Cells Institute Business Overview
Table 113. Human Stem Cells Institute Gene Therapy Product
Table 114. Human Stem Cells Institute Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 115. Human Stem Cells Institute Recent Development
Table 116. CSL Behring Company Details
Table 117. CSL Behring Business Overview
Table 118. CSL Behring Gene Therapy Product
Table 119. CSL Behring Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 120. CSL Behring Recent Development
Table 121. BioMarin Pharmaceutical Company Details
Table 122. BioMarin Pharmaceutical Business Overview
Table 123. BioMarin Pharmaceutical Gene Therapy Product
Table 124. BioMarin Pharmaceutical Revenue in Gene Therapy Business (2020-2025) & (US$ Million)
Table 125. BioMarin Pharmaceutical Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
Table 129. Authors List of This Report


List of Figures
Figure 1. Gene Therapy Picture
Figure 2. Global Gene Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy Market Share by Type: 2024 VS 2031
Figure 4. Viral Gene Therapy Features
Figure 5. Non-Viral Gene Therapy Features
Figure 6. Global Gene Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapy Market Share by Application: 2024 VS 2031
Figure 8. Neurological Diseases Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Gene Therapy Report Years Considered
Figure 12. Global Gene Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Gene Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gene Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Gene Therapy Market Share by Players in 2024
Figure 16. Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2024
Figure 18. North America Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Gene Therapy Market Share by Country (2020-2031)
Figure 20. United States Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapy Market Share by Country (2020-2031)
Figure 24. Germany Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy Market Share by Region (2020-2031)
Figure 32. China Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Gene Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 48. Novartis Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 49. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 50. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 51. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 52. Amgen Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 53. Roche Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 54. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 55. bluebird bio Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 56. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 57. SIBIONO Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 58. AnGes Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 59. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 60. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 61. CSL Behring Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 62. BioMarin Pharmaceutical Revenue Growth Rate in Gene Therapy Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies